Drug comparisons
Fremanezumab vs Rimegepant
Fremanezumab (Ajovy) vs Rimegepant (Nurtec): CGRP migraine drugs compared. Injection vs oral, preventive vs acute/preventive use, efficacy and safety.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when evaluating CGRP-targeted migraine therapies, choosing between a preventive injectable monoclonal antibody and an oral gepant for acute or preventive use.
Bottom line
Fremanezumab and Rimegepant both effectively target CGRP pathways for migraine but differ in route, dosing, and indications, so the better option is highly individualized.
All medication comparisons